Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EV/EBIT

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/EBIT(x) 160.28-382.3920.9315.1414.74

What is the latest EV/EBIT ratio of INDOCO REMEDIES ?

The latest EV/EBIT ratio of INDOCO REMEDIES is 160.28 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar2026160.28
Mar2025-382.39
Mar202420.93
Mar202315.14
Mar202214.74

How is EV/EBIT of INDOCO REMEDIES Trending?

Years EV/EBIT % Change
Mar2026 160.28
Positive
Mar2025 -382.39
Negative
Mar2024 20.93
38.24
Mar2023 15.14
2.71
Mar2022 14.74 -

Other Financial Ratios of INDOCO REMEDIES


Compare EV/EBIT ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,134.0 Cr -15.5% 6.7% -10.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -1.9% -3.7% 18.9% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 2.6% 11.1% 56% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr 0.2% 1.3% 38% Stock Analytics
CIPLA ₹110,515.0 Cr -1.5% -6.4% -12.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -1% -5.1% -8.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-15.5%

6.7%

-10.7%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses